Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.69% |
| 2 | Technology | 12.68% |
| 3 | Financials | 12.18% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Industrials | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
CALL
Teladoc Health
TDOC
$1.69B
| $496K | ﹤0.01% |
10,000
+5,000
| +100% | +$306K |
|
2952
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$357M
| $496K | ﹤0.01% |
+5,502
| New | +$713K |
|
|
NUVA
2953
CALL
DELISTED
NuVasive, Inc.
NUVA
| $496K | ﹤0.01% |
10,000
| – | – |
|
|
BOCH
2954
DELISTED
Bank of Commerce Holdings (CA)
BOCH
| $496K | ﹤0.01% |
45,245
-53,578
| -54% | -$623K |
|
|
CDTX
2955
DELISTED
Cidara Therapeutics
CDTX
| $495K | ﹤0.01% |
10,541
-11,312
| -52% | -$807K |
|
2956
Sociedad Química y Minera de Chile
SQM
$19.1B
| $495K | ﹤0.01% |
12,922
-315,182
| -96% | -$13.6M |
|
|
BRW
2957
Saba Capital Income & Opportunities Fund
BRW
$336M
| $493K | ﹤0.01% |
54,902
+26,142
| +91% | +$249K |
|
2958
ESCO Technologies
ESE
$8.18B
| $493K | ﹤0.01% |
7,470
-42,491
| -85% | -$2.76M |
|
2959
i3 Verticals
IIIV
$420M
| $493K | ﹤0.01% |
20,475
-20,985
| -51% | -$439K |
|
2960
Brighthouse Financial
BHF
$3.66B
| $492K | ﹤0.01% |
16,146
-193,585
| -92% | -$7.55M |
|
2961
Anterix
ATEX
$1.78B
| $490K | ﹤0.01% |
13,104
-48,376
| -79% | -$1.89M |
|
2962
TG Therapeutics
TGTX
$8.4B
| $490K | ﹤0.01% |
119,611
-161,704
| -57% | -$804K |
|
|
HZNP
2963
PUT
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $489K | ﹤0.01% |
25,000
| – | – |
|
2964
ANI Pharmaceuticals
ANIP
$1.84B
| $488K | ﹤0.01% |
10,831
-2,247
| -17% | -$118K |
|
2965
Digi International
DGII
$2.53B
| $488K | ﹤0.01% |
48,342
-5,591
| -10% | -$64.7K |
|
2966
AMC Global Media
AMCX
$451M
| $487K | ﹤0.01% |
8,866
-200,639
| -96% | -$11.7M |
|
|
NLSN
2967
DELISTED
Nielsen Holdings plc
NLSN
| $487K | ﹤0.01% |
+20,853
| New | +$540K |
|
2968
Altisource Portfolio Solutions
ASPS
$58.1M
| $484K | ﹤0.01% |
+2,691
| New | +$542K |
|
2969
GrafTech
EAF
$200M
| $483K | ﹤0.01% |
4,223
-204,299
| -98% | -$31.2M |
|
2970
Appian
APPN
$2.01B
| $481K | ﹤0.01% |
+18,023
| New | +$481K |
|
|
NXGN
2971
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $480K | ﹤0.01% |
31,705
-45,691
| -59% | -$784K |
|
2972
First Financial Bancorp
FFBC
$3.55B
| $479K | ﹤0.01% |
20,190
-63,074
| -76% | -$1.66M |
|
2973
Bio-Techne
TECH
$11.2B
| $479K | ﹤0.01% |
13,248
-315,128
| -96% | -$13.2M |
|
2974
CALL
Crown Holdings
CCK
$13.2B
| $478K | ﹤0.01% |
11,500
| – | – |
|
2975
AudioEye
AEYE
$75.8M
| $476K | ﹤0.01% |
+55,642
| New | +$411K |
|
Similar funds
Millennium Management's Q4 2018 Portfolio in Review
As of Q4 2018, Millennium Management held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Millennium Management withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Athenahealth, Inc. worth $135M.
- Millennium Management's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Millennium Management added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Millennium Management's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Millennium Management fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Millennium Management's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Millennium Management opened 702 new positions and closed 844 in Q4 2018.
- Millennium Management's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.